1 / 21

NITRIC OXIDE AND CARBON MONOXIDE: MODULATION OF INTRAOCULAR PRESSURE

NITRIC OXIDE AND CARBON MONOXIDE: MODULATION OF INTRAOCULAR PRESSURE. Claudio Bucolo and Filippo Drago*. Department of Experimental and Clinical Pharmacology, School of Medicine, University of Catania, Catania, Italy *Director PhD School of Neuropharmacology. NADPH. NADPH. O 2. H 2 O.

elle
Télécharger la présentation

NITRIC OXIDE AND CARBON MONOXIDE: MODULATION OF INTRAOCULAR PRESSURE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NITRIC OXIDE AND CARBON MONOXIDE: MODULATION OF INTRAOCULAR PRESSURE Claudio Bucolo and Filippo Drago* Department of Experimental and Clinical Pharmacology, School of Medicine, University of Catania, Catania, Italy *Director PhD School of Neuropharmacology

  2. NADPH NADPH O2 H2O NADP NADP HEME NADPH Cytocrome C (P450) Reductase Heme Oxygenase Fe CO BILIVERDIN Biliverdin reductase BILIRUBIN

  3. sGC Soluble guanilyl cyclase Heat shock Cellular stress U.V. Transition metals Metalloporphirine Adrenal glucocorticoids Phorbol esters Cytokines HO-2/3 HO-1 + Lypopolysaccaride + Costitutive Inducible HEME Apoptosis MAPK pathway Cytoprotection Vasomotor tone CO Endothelin-1 + Ca2+activated K+channels cGMP Platelet aggregation Vascular cell growth and proliferation GTP

  4. HO System (isoforms:HO-1, HO-2, HO-3) NOS System (isoforms: NOS-1, NOS-2,NOS-3) CO NO sGC cGMP

  5. CO NO - HO-2 HEME HO-1 - + NOS L-Arginine

  6. Inhibition of Nitric Oxide Synthase by L-NAME reduces IOP of rabbits • Taniguchi et al. Curr Eye Res 1998 • Kiel et al. Exp Eye Res 2001 • Giuffrida et al. J Ocular Pharmacol Ther 2003

  7. CARBON MONOXIDE MAY MODULATE THE INTRAOCULAR PRESSURE ?

  8. Experimental Models of Ocular Hypertension - Alpha-Chymotrypsyn • Single intraocular injection of -chymotrypsyn • After 4 weeks the rabbits in which the IOP became 15 mmHg higher than in untreated controlateral eye were admitted • Measurements: IOP (TonoPen) and PD (caliper) - Betamethasone • Multiple injection of betamethasone (subconjunctival) • After 4 weeks the rabbits in which the IOP became 15 mmHg higher than in untreated controlateral eye were admitted • Measurements: IOP and PD

  9. Experimental Design Ocular Hypertension α-chymotrypsin or betamethasone -6 0 6 12 24 48 hours Hemin 50, 75, 100 mg/Kg i.v. IOP ZnPP-IX 0.1 mg/Kg i.p.

  10. Pupil Diameter in Ocular Normotensive Rabbit PD (mm) at various time intervals after drug administration TREATMENT PD (mm) b.t.* 0.5h 1h 2h 3h 6h 12h 24h 48h Vehicle 6.800.20 6.850.20 6.800.15 6.850.20 6.850.20 6.800.30 6.850.20 6.850.15 6.850.20 Hemin 50mg/kg 6.950.30 6.980.15 6.950.30 7.010.25 6.950.15 6.980.25 6.900.20 7.000.30 6.980.30 Hemin 75mg/kg 6.900.15 6.900.20 6.900.30 6.950.15 6.950.30 6.920.30 6.940.20 6.900.25 6.910.30 Hemin 100mg/kg 6.850.20 6.850.20 6.800.20 6.820.25 6.850.30 6.830.25 6.850.20 6.850.30 6.850.25 * b.t.: before treatment • No change on Pupil Diameter has been observed

  11. CO NO - HO-2 HEME HO-1 + - + HEMIN NOS L-Arginine

  12. HO-1 AND RETINAL NEUROPROTECTION: RELEVANT STUDIES • HO-1 has cytoprotective effects on Müller cells and • plays an anti-inflammatory, anti-oxidative role • against the ischemia-reperfusion injury in rat • (Arai-Gaun et al. IOVS, 45, 2004) • HO-1-related carbon monoxide production • induced by flavonoids showed a protective effect • against ischemia-reperfusion injury in the rat retina • (Szabo et al. IOVS, 45, 2004) • Flavonoids protect human RPE cells from • oxidative-stress-induced death also through a • robust expression of HO-1 • (Hanneken et al. IOVS, 47, 2006)

  13. CONCLUSIONS • Hemin reduces IOP in rabbit with intraocular • hypertension. • This effect is possibly mediated by reduced • availability of ocular NO as a result of • increased production of CO by hemin • Hemin, and in general the HO-1 inducers • (i.e. phenolic compounds), may offer a • novel class of agents potentially effective • in the modulation of ocular hypertension • and retinal protection

  14. Acknowledgements Collaborators • Giovanna Privitera • Gian Marco Leggio • Department of Experimental and Clinical • Pharmacology, School of Medicine, • University of Catania, Catania, Italy • Marta Potenza • School of Ophthalmology, • University of Palermo, • Palermo, Italy Sponsorship This work was supported by a grant from M.I.U.R. Misura III.4 PON.RST

  15. Thanks and see you …

More Related